{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T02:45:24Z","timestamp":1785206724811,"version":"3.55.0"},"reference-count":46,"publisher":"National Academy of Sciences","issue":"31","license":[{"start":{"date-parts":[[2018,1,17]],"date-time":"2018-01-17T00:00:00Z","timestamp":1516147200000},"content-version":"vor","delay-in-days":184,"URL":"http:\/\/www.pnas.org\/site\/misc\/userlicense.xhtml"}],"funder":[{"DOI":"10.13039\/100000057","name":"HHS | NIH | National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["R01GM100887"],"award-info":[{"award-number":["R01GM100887"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006224","name":"DOE | LDRD | Argonne National Laboratory","doi-asserted-by":"publisher","award":["DE-AC02-06CH11357"],"award-info":[{"award-number":["DE-AC02-06CH11357"]}],"id":[{"id":"10.13039\/100006224","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.pnas.org"],"crossmark-restriction":true},"short-container-title":["Proc. Natl. Acad. Sci. U.S.A."],"published-print":{"date-parts":[[2017,8]]},"abstract":"<jats:title>Significance<\/jats:title>\n                  <jats:p>The search for anticancer drugs continues to be greatly pursued. The nucleoside analog gemcitabine, which targets ribonucleotide reductase (RR) as a diphosphate and DNA polymerases as a triphosphate, is the standard first-line treatment in patients with pancreatic cancer. However, its cytotoxicity to normal dividing tissues leads to unwanted side effects. Here, we have discovered a nonnucleoside RR inhibitor, naphthyl salicylic acyl hydrazone (NSAH), that has efficacy similar to gemcitabine and the potential to be modified to provide safer and more effective cancer therapies.<\/jats:p>","DOI":"10.1073\/pnas.1620220114","type":"journal-article","created":{"date-parts":[[2017,7,17]],"date-time":"2017-07-17T21:00:34Z","timestamp":1500325234000},"page":"8241-8246","update-policy":"https:\/\/doi.org\/10.1073\/pnas.cm10313","source":"Crossref","is-referenced-by-count":29,"title":["Potent competitive inhibition of human ribonucleotide reductase by a nonnucleoside small molecule"],"prefix":"10.1073","volume":"114","author":[{"given":"Md. Faiz","family":"Ahmad","sequence":"first","affiliation":[{"name":"Department of Pharmacology, School of Medicine, Case Western Reserve University, Cleveland, OH 44106;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Intekhab","family":"Alam","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, School of Medicine, Case Western Reserve University, Cleveland, OH 44106;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah E.","family":"Huff","sequence":"additional","affiliation":[{"name":"Department of Chemistry, Case Western Reserve University, Cleveland, OH 44106;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Pink","sequence":"additional","affiliation":[{"name":"Case Comprehensive Cancer Center, Case Western Reserve University, Cleveland, OH 44106;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheryl A.","family":"Flanagan","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, University of Michigan Medical School, Ann Arbor, MI 48109;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donna","family":"Shewach","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, University of Michigan Medical School, Ann Arbor, MI 48109;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tessianna A.","family":"Misko","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, School of Medicine, Case Western Reserve University, Cleveland, OH 44106;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy L.","family":"Oleinick","sequence":"additional","affiliation":[{"name":"Case Comprehensive Cancer Center, Case Western Reserve University, Cleveland, OH 44106;"},{"name":"Department of Radiation Oncology, School of Medicine, Case Western Reserve University, Cleveland, OH 44106;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William E.","family":"Harte","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, School of Medicine, Case Western Reserve University, Cleveland, OH 44106;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajesh","family":"Viswanathan","sequence":"additional","affiliation":[{"name":"Department of Chemistry, Case Western Reserve University, Cleveland, OH 44106;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael E.","family":"Harris","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, School of Medicine, Case Western Reserve University, Cleveland, OH 44106;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1686-4183","authenticated-orcid":false,"given":"Chris Godfrey","family":"Dealwis","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, School of Medicine, Case Western Reserve University, Cleveland, OH 44106;"},{"name":"Center for Proteomics and the Department of Chemistry, Case Western Reserve University, Cleveland, OH 44106"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"341","published-online":{"date-parts":[[2017,7,17]]},"reference":[{"key":"e_1_3_4_1_2","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/0022-2836(69)90056-4","article-title":"Role of effector binding in allosteric control of ribonucleoside diphosphate reductase","volume":"46","author":"Brown NC","year":"1969","unstructured":"NC Brown, P Reichard, Role of effector binding in allosteric control of ribonucleoside diphosphate reductase. J Mol Biol 46, 39\u201355 (1969).","journal-title":"J Mol Biol"},{"key":"e_1_3_4_2_2","doi-asserted-by":"crossref","first-page":"2447","DOI":"10.1073\/pnas.78.4.2447","article-title":"Mutator phenotypes in mammalian cell mutants with distinct biochemical defects and abnormal deoxyribonucleoside triphosphate pools","volume":"78","author":"Weinberg G","year":"1981","unstructured":"G Weinberg, B Ullman, Jr DW Martin, Mutator phenotypes in mammalian cell mutants with distinct biochemical defects and abnormal deoxyribonucleoside triphosphate pools. Proc Natl Acad Sci USA 78, 2447\u20132451 (1981).","journal-title":"Proc Natl Acad Sci USA"},{"key":"e_1_3_4_3_2","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/S0092-8674(00)81601-3","article-title":"The DNA replication and damage checkpoint pathways induce transcription by inhibition of the Crt1 repressor","volume":"94","author":"Huang M","year":"1998","unstructured":"M Huang, Z Zhou, SJ Elledge, The DNA replication and damage checkpoint pathways induce transcription by inhibition of the Crt1 repressor. Cell 94, 595\u2013605 (1998).","journal-title":"Cell"},{"key":"e_1_3_4_4_2","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/S1097-2765(00)80277-4","article-title":"A suppressor of two essential checkpoint genes identifies a novel protein that negatively affects dNTP pools","volume":"2","author":"Zhao X","year":"1998","unstructured":"X Zhao, EG Muller, R Rothstein, A suppressor of two essential checkpoint genes identifies a novel protein that negatively affects dNTP pools. Mol Cell 2, 329\u2013340 (1998).","journal-title":"Mol Cell"},{"key":"e_1_3_4_5_2","doi-asserted-by":"crossref","first-page":"6628","DOI":"10.1073\/pnas.1131932100","article-title":"Subcellular localization of yeast ribonucleotide reductase regulated by the DNA replication and damage checkpoint pathways","volume":"100","author":"Yao R","year":"2003","unstructured":"R Yao, , Subcellular localization of yeast ribonucleotide reductase regulated by the DNA replication and damage checkpoint pathways. Proc Natl Acad Sci USA 100, 6628\u20136633 (2003).","journal-title":"Proc Natl Acad Sci USA"},{"key":"e_1_3_4_6_2","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1111\/j.1432-1033.1969.tb00646.x","article-title":"Ribonucleoside diphosphate reductase. Purification of the two subunits, proteins B1 and B2","volume":"9","author":"Brown NC","year":"1969","unstructured":"NC Brown, ZN Canellakis, B Lundin, P Reichard, L Thelander, Ribonucleoside diphosphate reductase. Purification of the two subunits, proteins B1 and B2. Eur J Biochem 9, 561\u2013573 (1969).","journal-title":"Eur J Biochem"},{"key":"e_1_3_4_7_2","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1126\/science.271.5248.477","article-title":"Thiyl radicals in ribonucleotide reductases","volume":"271","author":"Licht S","year":"1996","unstructured":"S Licht, GJ Gerfen, J Stubbe, Thiyl radicals in ribonucleotide reductases. Science 271, 477\u2013481 (1996).","journal-title":"Science"},{"key":"e_1_3_4_8_2","doi-asserted-by":"crossref","first-page":"27705","DOI":"10.1074\/jbc.M605573200","article-title":"Enzymatically active mammalian ribonucleotide reductase exists primarily as an alpha6beta2 octamer","volume":"281","author":"Rofougaran R","year":"2006","unstructured":"R Rofougaran, M Vodnala, A Hofer, Enzymatically active mammalian ribonucleotide reductase exists primarily as an alpha6beta2 octamer. J Biol Chem 281, 27705\u201327711 (2006).","journal-title":"J Biol Chem"},{"key":"e_1_3_4_9_2","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1038\/nsmb.2007","article-title":"Structural basis for allosteric regulation of human ribonucleotide reductase by nucleotide-induced oligomerization","volume":"18","author":"Fairman JW","year":"2011","unstructured":"JW Fairman, , Structural basis for allosteric regulation of human ribonucleotide reductase by nucleotide-induced oligomerization. Nat Struct Mol Biol 18, 316\u2013322 (2011).","journal-title":"Nat Struct Mol Biol"},{"key":"e_1_3_4_10_2","doi-asserted-by":"crossref","first-page":"14324","DOI":"10.1073\/pnas.0706803104","article-title":"Enhanced subunit interactions with gemcitabine-5\u2032-diphosphate inhibit ribonucleotide reductases","volume":"104","author":"Wang J","year":"2007","unstructured":"J Wang, GJ Lohman, J Stubbe, Enhanced subunit interactions with gemcitabine-5\u2032-diphosphate inhibit ribonucleotide reductases. Proc Natl Acad Sci USA 104, 14324\u201314329 (2007).","journal-title":"Proc Natl Acad Sci USA"},{"key":"e_1_3_4_11_2","doi-asserted-by":"crossref","first-page":"9815","DOI":"10.1073\/pnas.1013274108","article-title":"Clofarabine 5\u2032-di and -triphosphates inhibit human ribonucleotide reductase by altering the quaternary structure of its large subunit","volume":"108","author":"Aye Y","year":"2011","unstructured":"Y Aye, J Stubbe, Clofarabine 5\u2032-di and -triphosphates inhibit human ribonucleotide reductase by altering the quaternary structure of its large subunit. Proc Natl Acad Sci USA 108, 9815\u20139820 (2011).","journal-title":"Proc Natl Acad Sci USA"},{"key":"e_1_3_4_12_2","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1021\/bi011653a","article-title":"A comprehensive model for the allosteric regulation of mammalian ribonucleotide reductase. Functional consequences of ATP- and dATP-induced oligomerization of the large subunit","volume":"41","author":"Kashlan OB","year":"2002","unstructured":"OB Kashlan, CP Scott, JD Lear, BS Cooperman, A comprehensive model for the allosteric regulation of mammalian ribonucleotide reductase. Functional consequences of ATP- and dATP-induced oligomerization of the large subunit. Biochemistry 41, 462\u2013474 (2002).","journal-title":"Biochemistry"},{"key":"e_1_3_4_13_2","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/j.chembiol.2012.05.015","article-title":"Clofarabine targets the large subunit (\u03b1) of human ribonucleotide reductase in live cells by assembly into persistent hexamers","volume":"19","author":"Aye Y","year":"2012","unstructured":"Y Aye, , Clofarabine targets the large subunit (\u03b1) of human ribonucleotide reductase in live cells by assembly into persistent hexamers. Chem Biol 19, 799\u2013805 (2012).","journal-title":"Chem Biol"},{"key":"e_1_3_4_14_2","first-page":"2847","article-title":"Metabolism and actions of 2-chloro-9-(2-deoxy-2-fluoro-beta-d-arabinofuranosyl)-adenine in human lymphoblastoid cells","volume":"55","author":"Xie C","year":"1995","unstructured":"C Xie, W Plunkett, Metabolism and actions of 2-chloro-9-(2-deoxy-2-fluoro-beta-d-arabinofuranosyl)-adenine in human lymphoblastoid cells. Cancer Res 55, 2847\u20132852 (1995).","journal-title":"Cancer Res"},{"key":"e_1_3_4_15_2","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1021\/acschembio.6b00303","article-title":"Cladribine and fludarabine nucleotides induce distinct hexamers defining a common mode of reversible RNR inhibition","volume":"11","author":"Wisitpitthaya S","year":"2016","unstructured":"S Wisitpitthaya, , Cladribine and fludarabine nucleotides induce distinct hexamers defining a common mode of reversible RNR inhibition. ACS Chem Biol 11, 2021\u20132032 (2016).","journal-title":"ACS Chem Biol"},{"key":"e_1_3_4_16_2","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1021\/jm00338a026","article-title":"Hydroxyurea. A new type of potential antitumor agent","volume":"6","author":"Stearns B","year":"1963","unstructured":"B Stearns, KA Losee, J Bernstein, Hydroxyurea. A new type of potential antitumor agent. J Med Chem 6, 201 (1963).","journal-title":"J Med Chem"},{"key":"e_1_3_4_17_2","first-page":"11","article-title":"An overview of the clinical experience with hydroxyurea","volume":"19","author":"Donehower RC","year":"1992","unstructured":"RC Donehower, An overview of the clinical experience with hydroxyurea. Semin Oncol 19, 11\u201319 (1992).","journal-title":"Semin Oncol"},{"key":"e_1_3_4_18_2","first-page":"65","article-title":"Radiosensitization of human solid tumor cell lines with gemcitabine","volume":"23","author":"Shewach DS","year":"1996","unstructured":"DS Shewach, TS Lawrence, Radiosensitization of human solid tumor cell lines with gemcitabine. Semin Oncol 23, 65\u201371 (1996).","journal-title":"Semin Oncol"},{"key":"e_1_3_4_19_2","doi-asserted-by":"crossref","first-page":"4105","DOI":"10.1200\/JCO.2011.34.8904","article-title":"Gemcitabine alone versus gemcitabine plus radiotherapy in patients with locally advanced pancreatic cancer: An Eastern Cooperative Oncology Group trial","volume":"29","author":"Loehrer PJ","year":"2011","unstructured":"Sr PJ Loehrer, , Gemcitabine alone versus gemcitabine plus radiotherapy in patients with locally advanced pancreatic cancer: An Eastern Cooperative Oncology Group trial. J Clin Oncol 29, 4105\u20134112 (2011).","journal-title":"J Clin Oncol"},{"key":"e_1_3_4_20_2","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1021\/jm00110a019","article-title":"2\u2032-Deoxy-2\u2032-methylenecytidine and 2\u2032-deoxy-2\u2032,2\u2032-difluorocytidine 5\u2032-diphosphates: Potent mechanism-based inhibitors of ribonucleotide reductase","volume":"34","author":"Baker CH","year":"1991","unstructured":"CH Baker, , 2\u2032-Deoxy-2\u2032-methylenecytidine and 2\u2032-deoxy-2\u2032,2\u2032-difluorocytidine 5\u2032-diphosphates: Potent mechanism-based inhibitors of ribonucleotide reductase. J Med Chem 34, 1879\u20131884 (1991).","journal-title":"J Med Chem"},{"key":"e_1_3_4_21_2","first-page":"3675","article-title":"Modulatory activity of 2\u2032,2\u2032-difluorodeoxycytidine on the phosphorylation and cytotoxicity of arabinosyl nucleosides","volume":"50","author":"Gandhi V","year":"1990","unstructured":"V Gandhi, W Plunkett, Modulatory activity of 2\u2032,2\u2032-difluorodeoxycytidine on the phosphorylation and cytotoxicity of arabinosyl nucleosides. Cancer Res 50, 3675\u20133680 (1990).","journal-title":"Cancer Res"},{"key":"e_1_3_4_22_2","first-page":"11","article-title":"Gemcitabine: A modulator of intracellular nucleotide and deoxynucleotide metabolism","volume":"22","author":"Heinemann V","year":"1995","unstructured":"V Heinemann, L Schulz, RD Issels, W Plunkett, Gemcitabine: A modulator of intracellular nucleotide and deoxynucleotide metabolism. Semin Oncol 22, 11\u201318 (1995).","journal-title":"Semin Oncol"},{"key":"e_1_3_4_23_2","first-page":"533","article-title":"Cellular elimination of 2\u2032,2\u2032-difluorodeoxycytidine 5\u2032-triphosphate: A mechanism of self-potentiation","volume":"52","author":"Heinemann V","year":"1992","unstructured":"V Heinemann, , Cellular elimination of 2\u2032,2\u2032-difluorodeoxycytidine 5\u2032-triphosphate: A mechanism of self-potentiation. Cancer Res 52, 533\u2013539 (1992).","journal-title":"Cancer Res"},{"key":"e_1_3_4_24_2","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.biocel.2014.12.010","article-title":"Inhibition of thymidylate synthase by 2\u2032,2\u2032-difluoro-2\u2032-deoxycytidine (Gemcitabine) and its metabolite 2\u2032,2\u2032-difluoro-2\u2032-deoxyuridine","volume":"60","author":"Honeywell RJ","year":"2015","unstructured":"RJ Honeywell, VW Ruiz van Haperen, G Veerman, K Smid, GJ Peters, Inhibition of thymidylate synthase by 2\u2032,2\u2032-difluoro-2\u2032-deoxycytidine (Gemcitabine) and its metabolite 2\u2032,2\u2032-difluoro-2\u2032-deoxyuridine. Int J Biochem Cell Biol 60, 73\u201381 (2015).","journal-title":"Int J Biochem Cell Biol"},{"key":"e_1_3_4_25_2","doi-asserted-by":"crossref","first-page":"37","DOI":"10.2217\/fon.14.221","article-title":"Ongoing selective internal radiation therapy-based studies in the treatment of liver-dominant metastatic colorectal cancer","volume":"10","author":"Heinemann V","year":"2014","unstructured":"V Heinemann, Ongoing selective internal radiation therapy-based studies in the treatment of liver-dominant metastatic colorectal cancer. Future Oncol 10, 37\u201339 (2014).","journal-title":"Future Oncol"},{"key":"e_1_3_4_26_2","doi-asserted-by":"crossref","first-page":"4115","DOI":"10.1016\/0006-2952(89)90693-X","article-title":"Modulation of deoxynucleotide metabolism by the deoxycytidylate deaminase inhibitor 3,4,5,6-tetrahydrodeoxyuridine","volume":"38","author":"Heinemann V","year":"1989","unstructured":"V Heinemann, W Plunkett, Modulation of deoxynucleotide metabolism by the deoxycytidylate deaminase inhibitor 3,4,5,6-tetrahydrodeoxyuridine. Biochem Pharmacol 38, 4115\u20134121 (1989).","journal-title":"Biochem Pharmacol"},{"key":"e_1_3_4_27_2","doi-asserted-by":"crossref","first-page":"26441","DOI":"10.1074\/jbc.272.42.26441","article-title":"Trapping of mammalian topoisomerase I and recombinations induced by damaged DNA containing nicks or gaps. Importance of DNA end phosphorylation and camptothecin effects","volume":"272","author":"Pourquier P","year":"1997","unstructured":"P Pourquier, , Trapping of mammalian topoisomerase I and recombinations induced by damaged DNA containing nicks or gaps. Importance of DNA end phosphorylation and camptothecin effects. J Biol Chem 272, 26441\u201326447 (1997).","journal-title":"J Biol Chem"},{"key":"e_1_3_4_28_2","first-page":"2499","article-title":"Gemcitabine (2\u2032,2\u2032-difluoro-2\u2032-deoxycytidine), an antimetabolite that poisons topoisomerase I","volume":"8","author":"Pourquier P","year":"2002","unstructured":"P Pourquier, , Gemcitabine (2\u2032,2\u2032-difluoro-2\u2032-deoxycytidine), an antimetabolite that poisons topoisomerase I. Clin Cancer Res 8, 2499\u20132504 (2002).","journal-title":"Clin Cancer Res"},{"key":"e_1_3_4_29_2","doi-asserted-by":"crossref","first-page":"9498","DOI":"10.1021\/acs.jmedchem.5b00929","article-title":"Identification of non-nucleoside human ribonucleotide reductase modulators","volume":"58","author":"Ahmad MF","year":"2015","unstructured":"MF Ahmad, , Identification of non-nucleoside human ribonucleotide reductase modulators. J Med Chem 58, 9498\u20139509 (2015).","journal-title":"J Med Chem"},{"key":"e_1_3_4_30_2","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1021\/jm030644s","article-title":"Glide: A new approach for rapid, accurate docking and scoring. 2. Enrichment factors in database screening","volume":"47","author":"Halgren TA","year":"2004","unstructured":"TA Halgren, , Glide: A new approach for rapid, accurate docking and scoring. 2. Enrichment factors in database screening. J Med Chem 47, 1750\u20131759 (2004).","journal-title":"J Med Chem"},{"key":"e_1_3_4_31_2","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1021\/jm0306430","article-title":"Glide: A new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy","volume":"47","author":"Friesner RA","year":"2004","unstructured":"RA Friesner, , Glide: A new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy. J Med Chem 47, 1739\u20131749 (2004).","journal-title":"J Med Chem"},{"key":"e_1_3_4_32_2","doi-asserted-by":"crossref","first-page":"4022","DOI":"10.1073\/pnas.0600443103","article-title":"Structures of eukaryotic ribonucleotide reductase I provide insights into dNTP regulation","volume":"103","author":"Xu H","year":"2006","unstructured":"H Xu, , Structures of eukaryotic ribonucleotide reductase I provide insights into dNTP regulation. Proc Natl Acad Sci USA 103, 4022\u20134027 (2006).","journal-title":"Proc Natl Acad Sci USA"},{"key":"e_1_3_4_33_2","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1038\/nsmb838","article-title":"Structural mechanism of allosteric substrate specificity regulation in a ribonucleotide reductase","volume":"11","author":"Larsson KM","year":"2004","unstructured":"KM Larsson, , Structural mechanism of allosteric substrate specificity regulation in a ribonucleotide reductase. Nat Struct Mol Biol 11, 1142\u20131149 (2004).","journal-title":"Nat Struct Mol Biol"},{"key":"e_1_3_4_34_2","doi-asserted-by":"crossref","first-page":"e07141","DOI":"10.7554\/eLife.07141","article-title":"Molecular basis for allosteric specificity regulation in class Ia ribonucleotide reductase from Escherichia coli","volume":"5","author":"Zimanyi CM","year":"2016","unstructured":"CM Zimanyi, PY Chen, G Kang, MA Funk, CL Drennan, Molecular basis for allosteric specificity regulation in class Ia ribonucleotide reductase from Escherichia coli. Elife 5, e07141 (2016).","journal-title":"Elife"},{"key":"e_1_3_4_35_2","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1158\/1535-7163.MCT-07-0068","article-title":"Mismatched nucleotides as the lesions responsible for radiosensitization with gemcitabine: A new paradigm for antimetabolite radiosensitizers","volume":"6","author":"Flanagan SA","year":"2007","unstructured":"SA Flanagan, BW Robinson, CM Krokosky, DS Shewach, Mismatched nucleotides as the lesions responsible for radiosensitization with gemcitabine: A new paradigm for antimetabolite radiosensitizers. Mol Cancer Ther 6, 1858\u20131868 (2007).","journal-title":"Mol Cancer Ther"},{"key":"e_1_3_4_36_2","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1016\/j.str.2012.05.009","article-title":"Tangled up in knots: Structures of inactivated forms of E. coli class Ia ribonucleotide reductase","volume":"20","author":"Zimanyi CM","year":"2012","unstructured":"CM Zimanyi, , Tangled up in knots: Structures of inactivated forms of E. coli class Ia ribonucleotide reductase. Structure 20, 1374\u20131383 (2012).","journal-title":"Structure"},{"key":"e_1_3_4_37_2","first-page":"485","article-title":"Interaction of 2-halogenated dATP analogs (F, Cl, and Br) with human DNA polymerases, DNA primase, and ribonucleotide reductase","volume":"34","author":"Parker WB","year":"1988","unstructured":"WB Parker, AR Bapat, JX Shen, AJ Townsend, YC Cheng, Interaction of 2-halogenated dATP analogs (F, Cl, and Br) with human DNA polymerases, DNA primase, and ribonucleotide reductase. Mol Pharmacol 34, 485\u2013491 (1988).","journal-title":"Mol Pharmacol"},{"key":"e_1_3_4_38_2","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/978-1-4899-2638-8_28","article-title":"Metabolism and action of 2\u2032,2\u2032-difluorodeoxycytidine: Self-potentiation of cytotoxicity","volume":"309","author":"Gandhi V","year":"1991","unstructured":"V Gandhi, P Huang, YZ Xu, V Heinemann, W Plunkett, Metabolism and action of 2\u2032,2\u2032-difluorodeoxycytidine: Self-potentiation of cytotoxicity. Adv Exp Med Biol 309A, 125\u2013130 (1991).","journal-title":"Adv Exp Med Biol"},{"key":"e_1_3_4_39_2","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1124\/mol.112.077735","article-title":"Small-molecule targeting of proliferating cell nuclear antigen chromatin association inhibits tumor cell growth","volume":"81","author":"Tan Z","year":"2012","unstructured":"Z Tan, , Small-molecule targeting of proliferating cell nuclear antigen chromatin association inhibits tumor cell growth. Mol Pharmacol 81, 811\u2013819 (2012).","journal-title":"Mol Pharmacol"},{"key":"e_1_3_4_40_2","doi-asserted-by":"crossref","first-page":"4028","DOI":"10.1073\/pnas.0600440103","article-title":"Structures of eukaryotic ribonucleotide reductase I define gemcitabine diphosphate binding and subunit assembly","volume":"103","author":"Xu H","year":"2006","unstructured":"H Xu, C Faber, T Uchiki, J Racca, C Dealwis, Structures of eukaryotic ribonucleotide reductase I define gemcitabine diphosphate binding and subunit assembly. Proc Natl Acad Sci USA 103, 4028\u20134033 (2006).","journal-title":"Proc Natl Acad Sci USA"},{"key":"e_1_3_4_41_2","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.jmb.2012.03.014","article-title":"Role of arginine 293 and glutamine 288 in communication between catalytic and allosteric sites in yeast ribonucleotide reductase","volume":"419","author":"Ahmad MF","year":"2012","unstructured":"MF Ahmad, , Role of arginine 293 and glutamine 288 in communication between catalytic and allosteric sites in yeast ribonucleotide reductase. J Mol Biol 419, 315\u2013329 (2012).","journal-title":"J Mol Biol"},{"key":"e_1_3_4_42_2","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1107\/S0907444904019158","article-title":"Coot: Model-building tools for molecular graphics","volume":"60","author":"Emsley P","year":"2004","unstructured":"P Emsley, K Cowtan, Coot: Model-building tools for molecular graphics. Acta Crystallogr D Biol Crystallogr 60, 2126\u20132132 (2004).","journal-title":"Acta Crystallogr D Biol Crystallogr"},{"key":"e_1_3_4_43_2","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1107\/S0909049503024130","article-title":"Recent developments in the PHENIX software for automated crystallographic structure determination","volume":"11","author":"Adams PD","year":"2004","unstructured":"PD Adams, , Recent developments in the PHENIX software for automated crystallographic structure determination. J Synchrotron Radiat 11, 53\u201355 (2004).","journal-title":"J Synchrotron Radiat"},{"key":"e_1_3_4_44_2","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1107\/S0907444996012255","article-title":"Refinement of macromolecular structures by the maximum-likelihood method","volume":"53","author":"Murshudov GN","year":"1997","unstructured":"GN Murshudov, AA Vagin, EJ Dodson, Refinement of macromolecular structures by the maximum-likelihood method. Acta Crystallogr D Biol Crystallogr 53, 240\u2013255 (1997).","journal-title":"Acta Crystallogr D Biol Crystallogr"},{"key":"e_1_3_4_45_2","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1107\/S0907444910045749","article-title":"Overview of the CCP4 suite and current developments","volume":"67","author":"Winn MD","year":"2011","unstructured":"MD Winn, , Overview of the CCP4 suite and current developments. Acta Crystallogr D Biol Crystallogr 67, 235\u2013242 (2011).","journal-title":"Acta Crystallogr D Biol Crystallogr"},{"key":"e_1_3_4_46_2","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/0003-2697(80)90165-7","article-title":"A simple, rapid, and sensitive DNA assay procedure","volume":"102","author":"Labarca C","year":"1980","unstructured":"C Labarca, K Paigen, A simple, rapid, and sensitive DNA assay procedure. Anal Biochem 102, 344\u2013352 (1980).","journal-title":"Anal Biochem"}],"updated-by":[{"DOI":"10.1073\/pnas.2021828117","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2020,11,9]],"date-time":"2020-11-09T00:00:00Z","timestamp":1604880000000}}],"container-title":["Proceedings of the National Academy of Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.pnas.org\/syndication\/doi\/10.1073\/pnas.1620220114","content-type":"unspecified","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/pnas.org\/doi\/pdf\/10.1073\/pnas.1620220114","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,7]],"date-time":"2022-06-07T11:45:55Z","timestamp":1654602355000},"score":1,"resource":{"primary":{"URL":"https:\/\/pnas.org\/doi\/full\/10.1073\/pnas.1620220114"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7,17]]},"references-count":46,"journal-issue":{"issue":"31","published-print":{"date-parts":[[2017,8]]}},"alternative-id":["10.1073\/pnas.1620220114"],"URL":"https:\/\/doi.org\/10.1073\/pnas.1620220114","relation":{},"ISSN":["0027-8424","1091-6490"],"issn-type":[{"value":"0027-8424","type":"print"},{"value":"1091-6490","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,7,17]]},"assertion":[{"value":"2017-07-17","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}